These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26827909)

  • 1. Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients.
    Zaenker P; Gray ES; Ziman MR
    Autoimmun Rev; 2016 May; 15(5):477-83. PubMed ID: 26827909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.
    Suurmond J; Diamond B
    J Clin Invest; 2015 Jun; 125(6):2194-202. PubMed ID: 25938780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of autoantibody signatures for common cancers.
    Kobayashi M; Katayama H; Fahrmann JF; Hanash SM
    Semin Immunol; 2020 Feb; 47():101388. PubMed ID: 31924500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
    Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
    Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the humoral immune response to cancer.
    Murphy MA; O'Leary JJ; Cahill DJ
    J Proteomics; 2012 Aug; 75(15):4573-9. PubMed ID: 22300580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis.
    Zanetti M; Glotz D; Rogers J
    J Immunol; 1986 Nov; 137(10):3140-6. PubMed ID: 3490512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response?
    Papuć E; Krupski W; Kurys-Denis E; Rejdak K
    J Neural Transm (Vienna); 2016 Apr; 123(4):455-61. PubMed ID: 26566902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
    Win TS; Pettigrew GJ
    Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autoantibody repertoire: searching for order.
    Plotz PH
    Nat Rev Immunol; 2003 Jan; 3(1):73-8. PubMed ID: 12511877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral mechanisms of atherogenesis.
    Batuca JR; Amaral MC; Alves JD
    Ann N Y Acad Sci; 2009 Sep; 1173():401-8. PubMed ID: 19758179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of human autoimmunity--autoantibodies versus autoimmune disease.
    Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME
    Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.
    Moulton VR; Tsokos GC
    J Clin Invest; 2015 Jun; 125(6):2220-7. PubMed ID: 25961450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-initiated beneficial and harmful immune responses.
    Barabas AZ; Cole CD; Lafreniere R
    Immunol Res; 2018 Dec; 66(6):783-789. PubMed ID: 30456543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.
    Heo CK; Bahk YY; Cho EW
    BMB Rep; 2012 Dec; 45(12):677-85. PubMed ID: 23261052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crossroads between cancer immunity and autoimmunity: antibodies to self antigens.
    Benvenuto M; Mattera R; Masuelli L; Tresoldi I; Giganti MG; Frajese GV; Manzari V; Modesti A; Bei R
    Front Biosci (Landmark Ed); 2017 Mar; 22(8):1289-1329. PubMed ID: 28199204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
    Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
    J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Forbidden" lymphocytes clones].
    Vorobev AA; Nesvizhskiĭ IuV
    Vestn Ross Akad Med Nauk; 1993; (9):17-9. PubMed ID: 7510176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to tumor-associated antigens: reporters from the immune system.
    Tan EM; Zhang J
    Immunol Rev; 2008 Apr; 222():328-40. PubMed ID: 18364012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.